Location History:
- Davis, CA (US) (2001 - 2020)
- Junction City, KS (US) (2021 - 2022)
Company Filing History:
Years Active: 2001-2022
Title: Innovations of Inventor Ning Huang
Introduction
Ning Huang is a prominent inventor based in Davis, CA (US), known for his significant contributions to the field of biotechnology. With a total of 14 patents to his name, he has made remarkable advancements in cell culture media, which are essential for various applications in biological research and pharmaceutical development.
Latest Patents
Ning Huang's latest patents include innovative formulations of cell culture media containing combinations of proteins. One of his notable inventions relates to cell culture media supplements or complete media compositions that comprise plant-produced heterologous recombinant human albumin. This invention outlines methods for creating the cell culture media and utilizing the supplemented media to enhance the viability, productivity, and growth characteristics of cultured cells. Another significant patent focuses on cell culture media supplemented with a plant-produced recombinant mammalian albumin supplement, which also aims to improve the growth characteristics of cultured cells.
Career Highlights
Throughout his career, Ning Huang has worked with notable companies such as Ventria Bioscience and Ventria Biosciences Inc. His work has been instrumental in advancing the capabilities of cell culture technologies, which are crucial for the development of therapeutic products and research applications.
Collaborations
Ning Huang has collaborated with esteemed colleagues, including Raymond L Rodriguez and Frank E Hagie. These collaborations have further enriched his research and contributed to the success of his innovative projects.
Conclusion
Ning Huang's contributions to the field of biotechnology through his patents and collaborations highlight his role as a leading inventor. His work continues to impact the development of effective cell culture media, paving the way for advancements in biological research and therapeutic applications.